Glycolysis-dominant metabolic pathway in cancer cells can promote their therapeutic resistance against radiotherapy (RT). Carbon monoxide (CO) as a glycolysis inhibitor can enhance the efficiency of RT. Herein, an X-ray responsive CO-releasing nanocomposite (HA@AuNC@CO) based on strong host-guest interactions between the radiosensitizer and CO donor for enhanced RT is developed. The encapsulated gold nanoclusters (CD-AuNCs) can effectively generate cytotoxic reactive oxygen species (ROS) under X-ray radiation, which not only directly inactivate cancer cells but also induce in situ CO gas generation from adamantane modified metal carbonyl (Ada-CO) for glycolysis inhibition. Both in vitro and in vivo results demonstrate that HA@AuNC@CO exhibits active targeting toward CD44 overexpressed cancer cells, along with excellent inhibition of glycolysis and efficient RT against cancer. This study offers a new strategy for the combination of gas therapy and RT in tumor treatment.
Keyphrases
- reactive oxygen species
- cancer therapy
- papillary thyroid
- high resolution
- dual energy
- squamous cell
- early stage
- radiation therapy
- drug delivery
- stem cells
- electron microscopy
- cell death
- squamous cell carcinoma
- locally advanced
- carbon dioxide
- magnetic resonance imaging
- magnetic resonance
- silver nanoparticles
- carbon nanotubes
- combination therapy
- energy transfer
- replacement therapy
- label free